Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2013; 19(37): 6272-6277
Published online Oct 7, 2013. doi: 10.3748/wjg.v19.i37.6272
Table 1 Baseline characteristics of patients undergoing laparoscopic distal pancreatectomy or open distal pancreatectomy for pancreatic solid pseudopapillary tumor n (%)
CharacteristicsLDP (n = 15)ODP (n = 13)P value
Age (yr)35.4 ± 13.035.2 ± 16.60.965
Sex0.035
Male0 (0.0)4 (30.8)
Female15 (100.0)9 (69.2)
BMI (kg/m2)20.8 ± 2.322.4 ± 6.10.392
Symptoms0.255
No10 (66.7)5 (38.5)
Yes5 (33.3)8 (61.5)
Comorbidity4 (26.7)4 (30.8)1.000
ASA score1.000
19 (60.0)8 (61.5)
26 (40.0)5 (38.5)
Tumor size (cm)5.1 ± 1.67.7 ± 4.10.050
Spleen preservation0.639
No13 (86.7)10 (76.9)
Yes2 (13.3)3 (23.1)
Combined resection1.000
Gallbladder0 (0.0)1 (7.7)
Gastric stromal tumor1 (6.7)0 (0.0)
Table 2 Surgical outcomes of laparoscopic distal pancreatectomy and open distal pancreatectomy for pancreatic solid pseudopapillary tumor n (%)
OutcomesLDP (n = 15)ODP (n = 13)P value
Operating time (min)171 ± 54178 ± 750.755
EBL (mL)149 ± 127580 ± 4000.002
Transfused patients1 (6.7)6 (46.2)0.029
First flatus time (d)1.9 ± 0.53.5 ± 0.90.000
Diet start time (d)2.3 ± 0.74.9 ± 2.10.000
Postoperative hospital stay (d)8.1 ± 1.712.8 ± 6.80.029
Morbidity5 (33.3)5 (38.5)1.000
Pancreatic fistula4 (26.7)4 (30.8)0.972
Grade A2 (13.3)2 (15.4)
Grade B0 (0.0)0 (0.0)
Grade C2 (13.3)2 (15.4)
Intra-abdominal abscess1 (6.7)0 (0.0)1.000
Pleural effusion0 (0.0)1 (7.7)0.464
Reoperation0 (0.0)1 (7.7)0.464
Percutaneous drainage2 (13.3)2 (15.4)1.000
Mortality0 (0.0)0 (0.0)-
Table 3 Pathological characteristics of patients undergoing laparoscopic distal pancreatectomy or open distal pancreatectomy for pancreatic solid pseudopapillary tumor n (%)
CharacteristicsLDP (n = 15)ODP (n = 13)P value
Harvested lymph nodes4.6 ± 4.16.4 ± 6.20.549
Negative surgical margin,15 (100.0)13 (100.0)-
Invasion of peripancreatic tissue4 (26.7)2 (15.4)0.655
Perineural invasion1 (6.7)1 (7.7)1.000
Liver metastasis0 (0.0)0 (0.0)-
Lymphatic metastasis0 (0.0)0 (0.0)-
Invasion of adjacent organs0 (0.0)0 (0.0)-
Angioinvasion0 (0.0)0 (0.0)-